Cardiff Oncology, Inc.CRDFNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-7856.66%
Near historical average
Percentile
P36
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-7230.78%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -7856.66% | -11.2% |
| 2024 | -7063.98% | +23.4% |
| 2023 | -9224.18% | +10.2% |
| 2022 | -10276.17% | -29.9% |
| 2021 | -7911.98% | -53.7% |
| 2020 | -5147.27% | +20.9% |
| 2019 | -6507.70% | -56.7% |
| 2018 | -4153.35% | +8.1% |
| 2017 | -4518.59% | +53.2% |
| 2016 | -9647.94% | - |